Table of Contents
Chapter 1. Global Genomics Personalized Health Market Executive Summary
1.1. Global Genomics Personalized Health Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Technology
1.3.2. By Test Type
1.3.3. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Genomics Personalized Health Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Genomics Personalized Health Market Dynamics
3.1. Market Drivers
3.1.1. Rise in Demand for Early Diagnosis
3.1.2. Increase in Investment in R&D Activities
3.2. Market Challenges
3.2.1. Lack of Skilled Professionals
3.3. Market Opportunities
3.3.1. Technological Advancements in Genomics
3.3.2. Expansion in Emerging Markets
Chapter 4. Global Genomics Personalized Health Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Genomics Personalized Health Market Size & Forecasts by Technology 2022-2032
5.1. Segment Dashboard
5.2. Global Genomics Personalized Health Market: Technology Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. NGS Platform
5.2.2. RT-PCR
5.2.3. Microarray
5.2.4. Genetic Analyzer
5.2.5. Others
Chapter 6. Global Genomics Personalized Health Market Size & Forecasts by Test Type 2022-2032
6.1. Segment Dashboard
6.2. Global Genomics Personalized Health Market: Test Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Oncology Testing
6.2.2. Infectious Disease Testing
6.2.3. Orphan Disease Testing
6.2.4. Autoimmune Disease Testing
6.2.5. Obstetrics Testing
6.2.6. Others
Chapter 7. Global Genomics Personalized Health Market Size & Forecasts by End User 2022-2032
7.1. Segment Dashboard
7.2. Global Genomics Personalized Health Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Academics & Research Institutes
7.2.2. Diagnostic Centers
7.2.3. Others
Chapter 8. Global Genomics Personalized Health Market Size & Forecasts by Region 2022-2032
8.1. North America Genomics Personalized Health Market
8.1.1. U.S. Genomics Personalized Health Market
8.1.1.1. Technology breakdown size & forecasts, 2022-2032
8.1.1.2. Test Type breakdown size & forecasts, 2022-2032
8.1.1.3. End User breakdown size & forecasts, 2022-2032
8.1.2. Canada Genomics Personalized Health Market
8.1.2.1. Technology breakdown size & forecasts, 2022-2032
8.1.2.2. Test Type breakdown size & forecasts, 2022-2032
8.1.2.3. End User breakdown size & forecasts, 2022-2032
8.2. Europe Genomics Personalized Health Market
8.2.1. U.K. Genomics Personalized Health Market
8.2.2. Germany Genomics Personalized Health Market
8.2.3. France Genomics Personalized Health Market
8.2.4. Spain Genomics Personalized Health Market
8.2.5. Italy Genomics Personalized Health Market
8.2.6. Rest of Europe Genomics Personalized Health Market
8.3. Asia-Pacific Genomics Personalized Health Market
8.3.1. China Genomics Personalized Health Market
8.3.2. India Genomics Personalized Health Market
8.3.3. Japan Genomics Personalized Health Market
8.3.4. Australia Genomics Personalized Health Market
8.3.5. South Korea Genomics Personalized Health Market
8.3.6. Rest of Asia Pacific Genomics Personalized Health Market
8.4. Latin America Genomics Personalized Health Market
8.4.1. Brazil Genomics Personalized Health Market
8.4.2. Mexico Genomics Personalized Health Market
8.4.3. Rest of Latin America Genomics Personalized Health Market
8.5. Middle East & Africa Genomics Personalized Health Market
8.5.1. Saudi Arabia Genomics Personalized Health Market
8.5.2. South Africa Genomics Personalized Health Market
8.5.3. Rest of Middle East & Africa Genomics Personalized Health Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. QIAGEN
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Illumina, Inc.
9.3.3. Thermo Fisher Scientific, Inc.
9.3.4. Bio-Rad Laboratories, Inc.
9.3.5. Hoffmann-La Roche AG
9.3.6. Lonza Group
9.3.7. Invitae Corp
9.3.8. Genetic Technologies Limited
9.3.9. Interleukin Genetics Inc.
9.3.10. Eastern Biotech and Life Sciences
9.3.11. DNA Genotek Inc.
9.3.12. uBiome, Inc.
9.3.13. XCode Life Sciences Private Limited
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes